The beloved BBC America series’ cast and producers revealed their favorite clones and got emotional talking about their final season. The Clone Club has gone Hollywood. (Okay, maybe only Crystal did.) ...

Orphan Black, the Canadian science fiction show that revolves around human cloning, will end on Saturday, August 12th after five darkly funny, gory seasons. The show began with a former British street ...

Just more than two months before Orphan Black begins its last season and self-described “final trip,” the sci-fi thriller starring Emmy-winning Tatiana Maslany looks to be going darker than ever. A ...

If you buy something from a Verge link, Vox Media may earn a commission. See our ethics statement. The show still makes time for characterization The fifth and final season really illustrates that ...

Designations for orphan drugs skyrocketed in 2017, with the Food and Drug Administration receiving 1.4 requests per day and granting those requests at a record rate of 1.3 per day. The FDA granted 77 ...

SPOILER ALERT: This story contains details of tonight’s Orphan Black series finale on BBC America. “We’ve talked since the beginning of wanting to do some kind of feature or some kind of two-hour ...

Acting on a request from three influential U.S. senators, the government’s accountability arm confirmed that it will investigate potential abuses of the Orphan Drug Act. The Government Accountability ...

Acting on a request from three influential U.S. senators, the government’s accountability arm confirmed that it will investigate potential abuses of the Orphan Drug Act. The Government Accountability ...

But lucrative financial incentives created by the Orphan Drug Act signed into law by President Ronald Reagan in 1983 succeeded far beyond anyone’s expectations. More than 200 companies have brought ...

The fourth season finale airs tonight at 10pm Eastern on BBC America. Since it first aired in 2013, the series has been widely acclaimed by critics and the public alike. Tatiana Maslany won a Critics’ ...

As payers continue to foot the bill for orphan drugs, sales of these rare disease treatments are forecast to grow 11 percent over the next five years — to $209 billion. And this is more than twice the ...